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Prevalence of dementia is expected to increase three- to
four-fold in the next 50 years. In 1986, New York State
established the Alzheimer's Disease and Other Dementias
Registry, one of a few such registries in the United States.
We identify surveillance challenges within the Registry.
Data quality — specifically, the attributes of complete-
ness and accuracy — is the primary challenge to the New
York State dementias registry. Completeness may be
undermined when hospitals and nursing homes fail to
report data, and hospital charts do not record dementia
diagnoses. Failure to record diagnoses may occur because
of diagnosis uncertainty, perceived stigma, clinical atten-
tion on the primary reason for hospitalization, and finan-
cial disincentives. Dementia is well recorded in nursing
home data because care planning requires frequent resi-
dent evaluations. The accuracy of recording specific forms
of dementia is limited because coding terminology has not
kept pace with physicians' perspectives on dementias.
Hospitals and nursing homes document dementia and
comorbidities more effectively among frail individuals and
those with advanced dementias than among individuals
who appear to be relatively healthy.
One way to overcome challenges of data quality is to
form partnerships with organizations that have expertise
in managing medical records and coding dementias. As
medical advances make early diagnoses more possible
outside the hospital or nursing home setting, we will
need to redesign the current surveillance system to cap-
ture this additional dementia data and ensure a repre-
sentative system.
Introduction
The purpose of this article is to provide a simple descrip-
tion of the New York State Department of Health (NYS-
DOH) Alzheimer's Disease and Other Dementias Registry
(the Registry) and outline several challenges. We do not
intend to offer a formal evaluation of the Registry,
although a thorough set of guidelines for conducting a for-
mal evaluation is available, and we use these guidelines as
framework for our article (1). A formal evaluation address-
es many topics and concerns in depth, but we focus here
primarily on only 2: describing the surveillance system
itself as well as the health-related event under surveil-
lance (dementia), and gathering evidence on the perform-
ance of the surveillance system.
Purpose and operation of surveillance system
The increasing prevalence of dementia among the aging
population in New York State during the 1980s prompted
concern about the ability to meet future service demands.
With encouragement from the New York City Chapter of
the Alzheimer's Association, advocates, concerned physi-
cians, and other stakeholders, a bill establishing the
Alzheimer's Disease and Other Dementias Registry
became law in 1986. The state legislature introduced sev-
eral bills between 1987 and 1992 to fund research on
Alzheimer's disease, but these bills were never enacted.
The NYSDOH funded the Registry, and the Registry
began to collect reports in 1988.
Article 20 of the New York State Public Health Law
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states that the purpose of the Registry is to collect infor-
mation necessary to "identify, locate and investigate the
occurrence, frequency, incidence, cause, effect and prog-
nosis of Alzheimer's disease" and maintain this informa-
tion for research purposes (2). Reporting is mandated for
physicians and facilities including "any governmental or
private agency, department, institution, clinic, laboratory,
hospital, nursing care facility, health maintenance organ-
ization, association of other similar entity that provides
medical care" (2).
The Registry requires a confidential case report to the
Department of Health each time a new case of Alzheimer's
disease or other dementia is diagnosed or confirmed in
New York State. In practice, the Registry receives demen-
tia reports primarily from the 400 hospitals and 700 nurs-
ing homes throughout the state. The state public health
law only includes Alzheimer's disease, but state regula-
tions (also in 1987) broadened reporting requirements to
include reports of other related dementias in addition to
Alzheimer's disease. By 1997, the state reporting form
included 47 codes for diseases and disorders related to
dementia based on the International Classification of
Diseases, 9th Revision, Clinical Modification coding sys-
tem (ICD-9-CM). Dementia can result from Alzheimer's
disease, stroke, Parkinson's disease, AIDS, and a number
of other less common illnesses.
The Registry collects data on types of dementia diag-
nosed as well as socio-demographic data such as age, race,
ethnicity, gender, and address. For identification purpos-
es, the Registry uses an individual's actual name or a
unique identifier formed from elements of the name and
social security number. The Registry gathers information
on the type of facility reporting data (hospital, nursing
home, physician's office, specialized Alzheimer's disease
program). The Registry also collects data on hospitaliza-
tion (length of stay and patient's destination at discharge).
The Registry staff has ranged from 2 to 4 professional or
clerical staff. Today, one full-time professional serves as
director of the Registry. Additional NYSDOH staff are
available as other duties permit. Limited staffing requires
that the operation of the Registry take advantage of infor-
mation collected by other existing data systems.
Public Health Importance of Alzheimer's Disease
and Other Dementias
The Centers for Disease Control and Prevention lists 7
parameters for assessing the public health importance of a
health-related event under surveillance. These include
indices of frequency and severity of disease, disparities or
inequities, costs, preventability, potential clinical course in
absence of intervention, and public interest. Let us first
examine dementia as a public health issue from the per-
spective of each of these parameters (with the exception of
potential clinical course in absence of intervention).
Frequency
The national mortality rate for Alzheimer's disease has
increased dramatically. The age-adjusted mortality rate in
1995 was 15 times the rate in 1979 (3). Mortality data alone
do not completely reflect the number of individuals who
have been affected by Alzheimer's disease. Nonetheless,
Alzheimer's disease has been added to the List of 72
Selected Causes of Death, diseases selected by the National
Center for Health Statistics for their public health impor-
tance (3). Although Alzheimer's disease is not usually
viewed as contributing to premature mortality, individuals
with Alzheimer's or other dementias are at increased risk
of death compared to individuals without dementia who
have other comparable health conditions (4). 
From study to study, estimates of the prevalence of
Alzheimer's disease vary by two- to ten-fold; when dis-
ease severity is specified, variation is reduced (5). Using
data on white individuals pooled from 20 studies, Hy and
Keller estimated that 1.7 million Americans were affect-
ed with mild to severe Alzheimer's disease in 1996 (5).
Other researchers estimated the prevalence of
Alzheimer's disease in the United States to be between
1.1 and 4.6 million in 1997 (6). Despite this range, public
health practitioners agree that the number of individuals
with Alzheimer's disease could triple or quadruple in the
next 50 years as a result of the aging of the U.S. popula-
tion (6,7). If new treatments that would both delay onset
and progression of disease are developed, the number of
affected individuals would double by 2050 rather than
quadruple (7). Dementia can also occur as a result of vas-
cular disease, HIV infection, Parkinson's disease, and
other diseases. 
Individuals with dementia account for nearly 58,000
hospitalizations each year in New York State. In 43% of
the hospitalizations among individuals with dementia,
the individual is discharged or returned to a skilled nurs-
ing facility (P.P.L., unpublished data, 2003).
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Dementia can result in a diminished quality of life not
only for the affected individual but also for the family.
Individuals with Alzheimer's disease experience problems
with memory and may also have other cognitive impair-
ments such as difficulties with language, inability to rec-
ognize and name objects or people, and loss of judgment
and problem-solving skills (8). Behavioral symptoms such
as agitation, wandering, and inappropriate behavior and
psychological problems including delusions or hallucina-
tions may also occur (9). Individuals with dementia are 5
times more likely to be admitted to a nursing home than
others of the same age (4). One fourth of individuals with
mild Alzheimer's disease progress to severe Alzheimer's
within 5 years; another quarter die in this time period (10). 
In a recent study of hospitalizations in New York State,
the majority of hospitalizations for individuals with a diag-
nosis of dementia occurred on an emergency basis (86%).
Many of the hospitalizations were due to serious illness
such as pneumonia and pneumonitis (13%), septicemia
(4%), and heart failure (4%) (P.P.L., unpublished data,
2003).
Disparities
In the United States African American and Caribbean
Hispanic individuals have been found to be at twice the
risk of Alzheimer's disease as white individuals (11). Data
from Medicare claims supports high risk of other demen-
tias in African American individuals as well (12).
In hospitalizations in New York State, the number of
hospitalizations among women with Alzheimer's disease
was twice the number among men. Nearly half of New
York hospitalizations that included a diagnosis of demen-
tia among women occurred for women over the age of 84;
for men, a third of New York hospitalizations that includ-
ed a diagnosis of dementia occurred among men over the
age of 84. African American individuals accounted for 10%
of all hospitalizations among New York State's hospital-
ized individuals over the age of 65, but were 14% of the
New York hospitalizations that included a diagnosis of
dementia (P.P.L., unpublished data, 2003).
Costs
Estimates of the cost of Alzheimer's disease vary widely —
but all are high (13). Medicare and Medicaid expenditures
are 50% to 100% higher among recipients with
Alzheimer's disease compared with other recipients
(14,15). Medicare beneficiaries with Alzheimer's disease
are hospitalized more frequently and stay in the hospital
longer than other Medicare beneficiaries but receive fewer
diagnostic and therapeutic procedures (16). Care for indi-
viduals with vascular dementia is even more costly (17).
Alzheimer's disease and other dementias are suggested as
major hidden contributors to the high costs of treating
other chronic diseases such as diabetes and cancer (17).
The value of lost productivity among caregivers substan-
tially exceeds the direct medical costs among community-
dwelling individuals with Alzheimer's disease (18).
Preventability
Medical advances are offering the opportunity to slow the
progress of Alzheimer's disease. The U.S. Food and Drug
Administration has approved a number of pharmacological
interventions that improve cognitive function in Alzheimer's
patients; more are being investigated (8). Preventing or con-
trolling the underlying disease can prevent dementias such
as vascular dementia or dementia resulting from HIV.
Public Interest 
Dementia does not appear in the popular news media to
the degree that other health issues, such as breast cancer,
do. This could be due to misconceptions about the inevitabil-
ity of cognitive decline with aging.
Challenges in Surveillance of Dementias
Level of Usefulness
The legislative intent of the law establishing the
Registry was to create a registry as a resource for describ-
ing the magnitude of dementia in New York State and
supporting research on dementia.
The Registry has contributed to its research mission in a
number of ways:
• A study of physician diagnosis of dementia established
baseline data for Healthy People 2000: National Health
Promotion and Disease Prevention Objectives and was
used to target educational interventions and teleconfer-
ences; 
• Creutzfeldt-Jakob Disease (CJD) surveillance linking
Registry, death records, and hospital data is conducted
as part of a national effort to more rapidly identify
potential instances of CJD and variant CJD in New York
State; and 
• Registry data was used in a study of caregivers' need for
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health and human services conducted by the Institute of
Gerontology, University at Albany, State University of
New York (19,20). 
Many of the challenges described in this paper have lim-
ited the usefulness of the Registry in the past and are cur-
rently being addressed.
System Attributes
The CDC guidelines list 9 attributes for evaluating a
surveillance system (1). These include simplicity, flexibili-
ty, data quality, acceptability, sensitivity, positive predic-
tive value, representativeness, timeliness, and stability. A
brief review of these attributes as they apply to the
Registry follows. A focus on data quality will serve to clar-
ify the challenges faced in conducting surveillance of
dementia.
Simplicity
Simplicity refers to structure and ease of operation of the
surveillance system (1). Simplicity is enhanced by use of
other existing sources of reporting data. Figure 1 illus-
trates the anticipated flow of information to the Registry
from nursing homes, and Figure 2 shows the flow from
hospitals.
Flexibility
Flexibility refers to how quickly a system can adapt to
changing information needs or operating conditions (1).
Because dementia is a chronic disease, information needs
and operating conditions change slowly, and flexibility is
not a critical issue. Nevertheless, the Registry seeks to
maximize flexibility by obtaining data from existing
resources, rather than collecting its own data in isolation.
The process of procuring data from other sources has not
been difficult, but the process of obtaining permissions and
developing programs to extract data has been time-con-
suming. Technology permits extraction of high-quality
data from other systems, facilitating operation of the
Registry with little staffing, but the Registry is only as
flexible as its existing data sources.
Data quality
Data quality reflects the completeness and validity of
data recorded (1). Data quality — specifically, complete-
ness and coding accuracy — is the primary challenge to
the Registry. The Registry relies on 2 primary data sources
for completeness of information: hospitals and nursing
homes. Between 1986 and early 2003, hospitals reported
data on paper forms sent directly to the Registry. During
this time, hospital reporting via paper forms yielded
approximately 20,000 reports each year. In comparison,
New York State's hospital discharge database received
more than 50,000 medical records that include a diagnosis
of dementia each year. The hospital discharge database
collects information on up to 15 ICD-9-CM diagnoses from
over 2.4 million hospitalizations statewide each year. In
spring 2003, the Registry eliminated paper reporting from
hospitals, converting to computerized extraction of hospi-
talizations with a dementia diagnosis from the hospital
discharge database. This eliminated the need for hospital
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Figure 1.
Proposed flow of data from nursing homes to New York State Department of
Health Alzheimer's Disease and Other Dementias Registry, 2003. MDSv2
indicates Minimum Data Set 2.0, Centers for Medicare and Medicaid
Services, U.S. Department of Health and Human Services. Permission to
use MDSv2 data for Dementias reporting is being sought by the Registry.staff to make separate reports to the Registry, and it also
eliminated the need for the Registry to spend resources on
data entry. The hospital discharge database locates addi-
tional reports on individuals with dementia, and it main-
tains quality control mechanisms and important hospital
relationships.
Use of the hospital discharge database does not elimi-
nate all concerns about completeness of hospital reporting.
Completeness also depends on dementia diagnoses being
recorded in medical records in the first place. Dementia
diagnoses may be underreported for several reasons. The
first reason is diagnostic uncertainty. Unlike a cancer
diagnosis, which is based on laboratory pathology,
Alzheimer's disease and most other dementias are diag-
nosed clinically. Although it is commonly believed that
Alzheimer's disease can only be definitively diagnosed at
autopsy, practice parameters developed by the American
Academy of Neurology indicate that Alzheimer's disease
can be diagnosed clinically with good reliability (21).
National Center for Health Statistics guidelines call for
coding discharge diagnoses that are suspected, possible, or
probable as if the condition "existed or was established"
(22). Because of uncertainties in assigning a diagnosis,
physicians may hesitate to record a clinical diagnosis or
possible diagnosis of dementia in the medical record.
Second, general practitioners have been found to delay
diagnoses of dementia because of embarrassment about
communicating the diagnosis (23). The degree to which
doctors hesitate is unknown. Third, financial disincentives
for reporting dementia have also existed. Insurers have
denied payment for services such as physical, occupation-
al, or speech therapy to patients with Alzheimer's disease
in the belief that patients could not benefit from therapy
(23,24). Automatic denial based solely on a diagnosis of
dementia has been prohibited since September 2001 (24).
Fourth, most individuals with dementia are hospitalized
for illnesses other than dementia, such as cardiovascular
disease or respiratory disease (P.P.L., unpublished data,
2003). Failure to record diagnoses may occur because of
clinical attention to the primary reason for hospitalization.
The degree to which hospitals vary in recording secondary
diagnoses is unknown.
Nursing homes provide another source of information on
patients with dementia. A diagnosis of dementia is likely
to be well recorded in nursing home data because nursing
homes are mandated to assess residents' abilities and lim-
itations frequently to provide a responsive plan of care.
Higher reimbursement rates for residents who require
more care may also encourage complete reporting of
dementia by nursing homes. Approximately 200,000
assessments are performed each year for nursing home
residents described as having dementia; the evaluations
are recorded in the Centers for Medicare and Medicaid
Services' Minimum Data Set. A registered nurse coordi-
nates the assessment and certifies that the assessment
form is complete. Other licensed health professionals, such
as the attending physician, social workers, dietitians, and
physical therapists may be assigned to complete relevant
sections of the assessment instrument.
The Registry is now pilot-testing the ability of this com-
puterized database to replace paper reporting from nurs-
ing homes. Preliminary data show that only one third of
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Figure 2. 
Flow of data from hospitals to New York State Department of Health
Alzheimer's Disease and Other Dementias Registry, 2003.VOLUME 1: NO. 1
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nursing homes that reported using the Minimum Data Set
also completed paper Registry reporting forms. Use of the
Minimum Data Set to retrieve information on nursing
home residents with dementia would eliminate the need
for nursing home staff to report data to 2 systems, and
Registry staff would not need to enter data separately.
Administrators of the nursing home data system monitor
quality control, provide training on filling out forms, and
maintain relationships with nursing homes.
Accuracy in coding the dementia diagnosis is another
important component of data quality. Diagnoses in med-
ical records are currently coded and reported under the
ICD-9-CM coding system. Conceptualization of Alzheimer's
disease and other dementias has evolved over time (25),
and coding reflects this evolution. Under the ICD-9-CM
system, dementias are grouped with psychotic mental dis-
orders, while Alzheimer's disease is classified as a nervous
system disorder. Consequently, reporting 2 codes is neces-
sary for some dementias: one to document dementia symp-
toms and another to document the disease responsible for
the dementia, such as Alzheimer's or Parkinson's disease.
ICD-9-CM terminology further complicates coding accura-
cy because it has not kept pace with terms used by physi-
cians and neurologists in discussing dementias. Recent
practice parameters from the American Academy of
Neurology discuss criteria for diagnosing Alzheimer's dis-
ease, vascular dementia, dementia with Lewy Bodies, and
frontotemporal dementia (21). Several ICD-9-CM codes
document Alzheimer's disease. In contrast, no ICD-9-CM
codes existed prior to October 2003 for frontotemporal
dementia or dementia with Lewy Bodies (26). As a result,
the consistency of coding dementias may vary from facili-
ty to facility, given differences between how physicians
describe dementia and how the coding system offers
options. A study of hospitalizations that included a diag-
nosis of dementia found various dementia diagnoses
recorded for the same patient both over time and within
the same hospital stay (P.P.L., unpublished data, 2003).
The Medical Economics and Management Subcommittee
of the American Academy of Neurology is working to
develop an ICD-9-CM Dementia coding index to address
some of these issues (written communication, Gina
Gjorvad, American Academy of Neurology, 31 July 2003).
Acceptability
Acceptability indicates the willingness of persons and
organizations to participate in the surveillance system (1).
Use of existing sources of data from hospitals and nursing
homes clearly enhances acceptability of the Registry.
Uncertainty about diagnosing dementia and a possible
perceived stigma or embarrassment among physicians
may pose a significant obstacle to acceptability, but the
extent of significance is unknown. A recent review of hos-
pitalizations found one third of men and nearly half of
women hospitalized with a recorded dementia diagnosis
were over age 85, suggesting that physicians may be more
willing to record a dementia diagnosis for older patients
(P.P.L, unpublished data, 2003).
Sensitivity
Sensitivity refers to the proportion of disease cases
detected by the surveillance system as well as the ability
to detect outbreaks, including the ability to monitor
changes in the number of cases over time (1).
Historically, the majority of Registry reports have come
from hospitals and nursing homes. The mandate to report
Alzheimer's disease and other dementias is not contained
in the same section of New York State public health law as
communicable diseases. Direct reporting of communicable
diseases is a traditional public health activity that is famil-
iar to physicians and county health departments.
Reporting of dementia is less familiar to physicians than
reporting communicable diseases, particularly since coun-
ty health departments are not used as a conduit of demen-
tia data to the state. Resources have not permitted the
degree of outreach and education necessary to inform
physicians of their duty to report or to monitor complete-
ness and accuracy of their reporting.
As a result, the surveillance system is sensitive enough
to monitor changes over time, but is most sensitive to indi-
viduals with dementia who are frail or have comorbid con-
ditions and least sensitive to individuals in relatively good
health or those diagnosed in the early stages of dementia.
The idea of representativeness is discussed further below.
Predictive Value Positive
Predictive value positive is the proportion of individuals
reported with diesease that actually have disease (1).
Factors that limit the recording of dementia diagnoses in
medical charts also make false-positive reports of demen-
tia unlikely.
Representativeness
Representativeness is a measure of how accurately the
surveillance system describes the occurrence and distribu-
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represents individuals with dementia who are frail or who
have comorbid conditions better than it represents indi-
viduals in relatively good health or individuals diagnosed
at early stages of disease, mainly because reports are
made primarily from hospitals and nursing homes.
Medical advances are making early diagnoses more possi-
ble. As more individuals receive early diagnoses outside
the hospital or nursing home setting, the current system of
surveillance will not be able to capture these diagnoses,
and the system will become less representative of the pop-
ulation with dementia.
Timeliness
Timeliness reflects the speed between surveillance sys-
tem steps (1). Timeliness is less important to surveillance
of chronic diseases such as dementia compared to surveil-
lance of communicable diseases, which demands a rapid
public health response (1). Long-range planning of support
services is enhanced by information on statistical trends in
Alzheimer's disease and other dementias. The NYSDOH
provides small grants to Alzheimer's Disease Assistance
Centers and Alzheimer's Disease Community Service
Programs in New York State. Assistance Centers provide
diagnosis, assessment and treatment for patients, educa-
tional/training services for health care professionals, care
planning for the patient and family and serve as a clear-
inghouse for information on dementia. Community Service
Programs provide respite care, caregiver training, support
group services, and information and referral to patients
and families. Information on trends in Alzheimer's disease
and other dementias will enhance long-range planning of
services by these and other groups. Staff members from
the Registry have participated in annual meetings of these
organizations.
Stability
Stability refers to the reliability (i.e., the ability to col-
lect, manage, and provide data without failure) and avail-
ability (i.e., the ability to be operational when needed) of a
surveillance system (1). Because timeliness is not crucial
to dementia surveillance, the Registry is considered to be
a stable system — that is, reliable and available with given
resources.
Conclusions and Recommendations
This article has highlighted data quality as the main
challenge to surveillance of dementias in New York State.
Data quality is likely to be the primary challenge to other
surveillance systems focusing on dementias. A system that
obtains reports from existing hospital and nursing home
databases can improve completeness of reporting, but such
a system may be biased toward documenting illness in
frail individuals with other health conditions as well as
those living in nursing homes. Terminology reflected in
ICD-9-CM coding has not kept pace with terms used by
physicians and neurologists in discussing dementias. The
accuracy of coding dementias in medical records from facil-
ity to facility is unknown; differences exist between how
dementias are described in medical charts and how they
are translated into coding choices.
A number of additional activities may improve com-
pleteness and accuracy of dementia reporting from nurs-
ing homes and hospitals. These recommended activities
include:
• Educating physicians on how to diagnose and code for
dementia accurately once American Academy of
Neurology guidelines are finalized. 
• Examining patterns of dementia diagnoses reported lon-
gitudinally for a sample of patients from different
sources to assess the consistency of dementia diagnoses. 
• Enlisting the state's professional society for medical
information management as a partner to highlight the
importance of completely recording diagnoses of demen-
tia and to help make informed recommendations about
best practices in coding. 
As medical advances lead to earlier diagnoses of demen-
tia in individuals without other health conditions, we will
need to develop better mechanisms for capturing data
from organizations other than hospitals and nursing
homes. A number of approaches could be tested:
• Conduct a capture-recapture study using existing data
sources to estimate the proportion of individuals with
dementias missed in current surveillance. Such a study
was recently undertaken by the South Carolina
Alzheimer's Disease Registry; use of capture-recapture
methodology was shown to identify 25% more individu-
als with dementia in South Carolina for an overall
prevalence of 14% among individuals 65 years of age
and older (27). 
• Partner with neurology practices and community-based
organizations providing support services to individuals
with Alzheimer's disease to study the proportion of indi-
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viduals with dementia who go unreported. 
• Explore the utility of other databases, such as Medicare
encounter data. 
Despite the limitations of dementia surveillance, sur-
veillance data are useful to individuals and agencies
involved in monitoring trends, conducting research, or
planning future services for an aging population. To that
end, the Registry will publish its first report on hospital-
izations that include a diagnosis of dementia in New York
State. The report is scheduled for release at the end of
2003. Its intended audience includes public health practi-
tioners and planners, clinicians, Alzheimer's Disease
Assistance Centers, Alzheimer's Disease Community
Service Programs, and reporting facilities. By studying
hospitalizations, the Registry can begin to characterize the
experience of New York's frailest residents coping with
dementias and other illnesses.
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